OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
View All Citations >>
Home All anti-HACE1 antibodies
Anti-HACE1 Antibody EPR7962
Also for HACE1 (NM_020771)
Homo sapiens HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 (HACE1)
HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1
A synthetic peptide corresponding to residues in human HACE1 was used as an immunogen.
Store at -20 °C. Buffer: Antibody buffer, sodium azide, glycerol, and BSA. Stable for 12 months from date of receipt.
Human, Mouse, Rat
WB: 1:1,000 - 10,000; FC: 1:100 - 500;
HACE1 is an E3 ubiquitin ligase whose expression is greatly reduced in sporadic Wilms' tumors (1). It is widely expressed in human tissues, including mature pediatric and fetal kidney (2). Moreover, HACE1 is reported to be a tumor suppressor (1).
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis on (A) 293T and (B) SH-SY5Y cell lysates using anti-HACE1 RabMAb.
Immunohistochemical analysis of paraffin-embedded human astrocytoma tissue using anti-HACE1 RabMAb.